Mosaic ImmunoEngineering Competitors and Similar CompaniesClear all

Senda Biosciences's competitors and similar companies include NextCure and TC BioPharm.

	Senda Biosciences Senda Biosciences (formerly known as Kintai Therapeutics) is a company developing a platform that deconstructs nature-provided codes for therapeutic purposes.	NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.	TC BioPharm TC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products.
Founding Date	Founding Date 2017	Founding Date 2015	Founding Date 2013
Type	Type Subsidiary	Type Public	Type Public
Tags	Tags Technology biotech life sciences oncology platform therapy	Tags Healthcare Technology biotech drug development oncology pharma platform therapy	Tags Technology biotech clinical research oncology platform therapy
Locations	Locations Cambridge, US HQ	Locations Beltsville, US HQ	Locations Holytown, GB HQ Leiden, NL Edinburgh, GB London, GB
Employees	Employees 16	Employees N/A	Employees 41
Valuation ($)	Valuation ($) N/A	Valuation ($) 39.2 m	Valuation ($) 926.7 k
Financial
Net income	Net income N/A	Net income ($55.8m) (FY, 2025)	Net income (£12.2m) (FY, 2024)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 160m	Total funding raised $ 33.2m

For sources of this data, please see the company profile

Beltsville, US

NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.

Holytown, GB

Employees

TC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products.

Financial